In contrast, neither TLR4 nor TLR2 stimulation with LPS and bacterial peptidoglycan, respectively, could prevent mesothelioma development (Figure 4A, p = 0.62 and 0.91, respectively). The gene discussed is TLR4; the disease is mesothelioma.